Pfizer Inc. (NSE: PFIZER, NYSE: PFE, ETR: PFE), a leading pharmaceutical company in the U.S., has entered into a partnership with China’s Shanghai Pharmaceutical Holding Co., Ltd (SHA: 601607; SPH) to establish a long-term collaboration in the vaccine sector. The collaboration will focus on product promotion, introduction of innovative products, and policy research. Financial details of the agreement were not disclosed.
This strategic alliance aims to combine Pfizer’s global vaccine expertise with Shanghai Pharmaceutical’s extensive market presence and regulatory knowledge in China. By working together, the two companies intend to enhance vaccine accessibility and contribute to public health initiatives within the country.- Flcube.com
